Status:
UNKNOWN
Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents
Lead Sponsor:
The University of Hong Kong
Conditions:
COVID19
Herbal Medicine
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Chinese medicine has been used for thousands of years in the treatment of epidemic diseases. Through the long-term struggle with the epidemic, Investigators have accumulated and explored a lot of prev...
Detailed Description
In December 2019, COVID-19 has been outbreaks in a series regions of China and abroad. Its pathogen was initially identified as a new coronavirus with single strand positive RNA. COVID-19 is considere...
Eligibility Criteria
Inclusion
- Age 18 or above, regardless of gender;
- For COVID-19 susceptible individuals, according to the criteria of "Self-test for classification and judgment of body constitution by TCM theory", subjects with deficiency of Qi with either Yin or Yang will meet the inclusion criteria;
- No previous allergy to traditional Chinese medicine;
- Be able to understand Chinese questionnaire;
- Willing to participate in the study.
Exclusion
- Syndrome types are not related to "deficiency of Qi and Yang" and "deficiency of Qi and Yin";
- Suspected or confirmed COVID-19 patients;
- Fever, body temperature \> 37°C with cough and other respiratory symptoms;
- Those who have visited the epidemic area and have not completed isolation for 14 days after returning to Hong Kong
Key Trial Info
Start Date :
April 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2022
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT04668222
Start Date
April 30 2021
End Date
November 30 2022
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong
Hong Kong, Hong Kong, China, Hong Kong, 999077